Fascin inhibitor increases intratumoral dendritic cell activation and anti-cancer immunity is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 51 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA193815
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA193815
National Institutes of Health
Grant: 5R01CA193815-02
Targeting fascin to block tumor metastasis
FWCI
2.86
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 5 of Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Additional file 5 of Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Additional file 1 of Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Additional file 2 of Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Additional file 4 of Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Additional file 3 of Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Additional file 4 of Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Additional file 1 of Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Additional file 3 of Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Additional file 2 of Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization